Read the original article here. Halifax, Nova Scotia, October 3, 2018 – Sona Nanotech Inc. (CSE: SONA) (“Sona” or the “Company”) is pleased to announce that the Canadian Securities Exchange (CSE) has approved the Company’s application to list its common shares on the CSE.  Effective October 4, 2018, the Company’s shares will commence trading on…

See original article here Darren Rowles is CEO and president of Nova Scotia-based biotech firm Sona Nanotech. Having worked with gold nanoparticles for the past 15 years, he explains the role that they currently play in the healthcare industry and their revolutionary potential. Colloidal gold, the suspension of gold nanoparticles in liquid, has been used for…

See original article written in Spring 2015 edition of LINK magazine High aspect Gold Nanorods are emerging as a very useful material, with promising applications in “in vivo” medical applications such as; diagnostic imaging and hyperthermal cancer treatment. The use of gold nanorod’s in these applications have been hampered by the fact that current synthesis…

2015 © Copyright - Bionova